Kevin A Roth

Title: Kevin A Roth: Innovator in Gastrin Releasing Peptide-Like Peptides

Introduction

Kevin A Roth is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of novel peptides with gastrin releasing peptide-like activity. His work has implications for various pharmaceutical applications.

Latest Patents

Kevin A Roth holds a patent for "Gastrin releasing peptide-like peptides." This patent describes novel peptides that have been isolated from rat and guinea pig brain extracts and synthesized using solid phase peptide synthesis methods. The specific structures of these peptides are Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-NH.sub.2 and Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH.sub.2. These GRP-like peptides are useful as pharmaceuticals to lower body temperature, increase respiratory activity, reduce food intake, stimulate pancreatic hormone release, stimulate pituitary hormone release, and suppress thyroid hormone release in mammals. Kevin A Roth has 1 patent to his name.

Career Highlights

Kevin A Roth is affiliated with Leland Stanford Junior University, where he has been involved in groundbreaking research. His work has contributed to advancements in understanding peptide functions and their potential therapeutic applications.

Collaborations

Some of his notable coworkers include Robin G Lorenz and Eckard Weber, who have collaborated with him on various research projects.

Conclusion

Kevin A Roth's innovative work in gastrin releasing peptide-like peptides showcases his commitment to advancing pharmaceutical science. His contributions have the potential to impact various medical fields significantly.